Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (61248)	6/3/1999 11:42:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 132070

Thursday June 3, 10:50 am Eastern Time Company Press Release SOURCE: Duramed Pharmaceuticals, Inc. Duramed Receives Patent for Tablet Composition of Cenestin * Patent Reinforces Value of Slow Release Composition of Duramed's Hormone Products * Patent Covers Cenestin/Medroxyprogesterone Combination as Well as Other Anticipated Cenestin Combination Products Through July 26, 2015 * Patent is a Significant Part of Duramed's Female Healthcare Agenda ************* Thanks for the lead, Michael. Am studying it. Peter.... thanks for the commentary. I honestly believe that liquidity will come back for many of the "good science" companies, or that they'll get picked off near-term at nice premiums. I continue to believe that MLNM, for example, should use its strong currency, such that a "good/big science" biotech can pick off the "good/little science" biotechs. Cheers! Rick

To: Knighty Tin who wrote (61248)	6/3/1999 2:58:00 PM
From: Knighty Tin	Read Replies (4) \| Respond to of 132070

To All, I made the following moves today. 1. I sold my Rambus June 70 and 75 puts. The soap opera about the IBM story means that it will take a few more weeks for this one to start heading in the right direction again. I still have July 70s and June 60s. 2. I am in the process of rolling my Intel June 55s down and out to October 45s. Only a 150%er on the Junes, but time is getting scarce. 3. I bought a second third of Duramed. 4. I bought some MU July 35s. That looks to be the sweet spot with the negative earnings due after June expiration.